Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

Summary

The purpose of this study is to determine whether on course (6 cycles) of consolidation therapy with Revlimid can shrink or slow the growth of Chronic Lymphocytic Leukemia (CLL) in the bone marrow.

Timeline

Start

2011-11

Primary completion

2014-05

Completion

2014-05

Outcome

Outcome not reported

Stopped: “interim analysis showed that the trial will not meet the interim endpoint.”

Drugs

Indications